Johnson & Johnson is pulling out all the stops
in its efforts to turn around its medical devices business. After a
restructuring early this year, the J&J medical device business
actually grew--albeit only by 0.7%--to $6.2 billion last quarter.
The pharma's arm that invests in new technology,
Johnson & Johnson Innovation (JJI), is doing its bit to try to help
encourage the success of those efforts in the long term. It’s creating
the new Center for Device Innovation at the Texas
Medical Center (TMC) in Houston, which is intended to enable the entire
process of creating “breakthrough” medical devices, the company said.
No comments:
Post a Comment